1. Home
  2. EVTL vs IVVD Comparison

EVTL vs IVVD Comparison

Compare EVTL & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$0.78

Market Cap

235.6M

Sector

Industrials

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

N/A

Current Price

$0.94

Market Cap

201.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVTL
IVVD
Founded
2016
2020
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.6M
201.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
EVTL
IVVD
Price
$0.78
$0.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$12.70
$8.75
AVG Volume (30 Days)
9.0M
3.6M
Earning Date
03-24-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
N/A
$53,426,000.00
Revenue This Year
N/A
$61.57
Revenue Next Year
N/A
$41.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
110.47
52 Week Low
$0.74
$0.53
52 Week High
$7.35
$3.07

Technical Indicators

Market Signals
Indicator
EVTL
IVVD
Relative Strength Index (RSI) 28.04 63.56
Support Level N/A $0.69
Resistance Level $1.42 $1.01
Average True Range (ATR) 0.08 0.08
MACD 0.01 0.04
Stochastic Oscillator 6.40 75.07

Price Performance

Historical Comparison
EVTL
IVVD

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Share on Social Networks: